{"id":"tauroursodeoxycholic-acid-capsules","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It does this by inhibiting the activation of the inositol-requiring enzyme 1 alpha (IRE1α) and the protein kinase RNA-like ER kinase (PERK), which are key components of the UPR. This leads to a reduction in the production of pro-inflammatory cytokines and an improvement in cellular function.","oneSentence":"Tauroursodeoxycholic acid is a bile acid derivative that modulates the unfolded protein response (UPR) and reduces endoplasmic reticulum stress.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:41.935Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Amyotrophic lateral sclerosis (ALS)"}]},"trialDetails":[{"nctId":"NCT04114292","phase":"PHASE1","title":"TUDCA as a Therapy for Ulcerative Colitis (UC)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-17","conditions":"Ulcerative Colitis","enrollment":14},{"nctId":"NCT07457632","phase":"PHASE2","title":"Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Diabetic Macular Edema (DME)","enrollment":69},{"nctId":"NCT07357467","phase":"","title":"Effect of Oral Supplement on Influenza Vaccine Long-term Response","status":"NOT_YET_RECRUITING","sponsor":"Tsinghua University","startDate":"2026-03","conditions":"Influenza, Immunosenescence","enrollment":30},{"nctId":"NCT04001647","phase":"EARLY_PHASE1","title":"Targeting ER Stress in Vascular Dysfunction","status":"TERMINATED","sponsor":"Colorado State University","startDate":"2019-06-01","conditions":"Vasodilation, Arterial Stiffness","enrollment":17},{"nctId":"NCT06827873","phase":"NA","title":"Effect of Oral Supplements for Influenza Vaccine Response","status":"NOT_YET_RECRUITING","sponsor":"Tsinghua University","startDate":"2025-02","conditions":"Influenza Vaccine Response","enrollment":45},{"nctId":"NCT03800524","phase":"PHASE3","title":"Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS","status":"UNKNOWN","sponsor":"Humanitas Mirasole SpA","startDate":"2019-02-22","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":337},{"nctId":"NCT03423121","phase":"PHASE1, PHASE2","title":"A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-06-19","conditions":"Progressive Multiple Sclerosis","enrollment":59},{"nctId":"NCT05753852","phase":"PHASE3","title":"Open Label Extension of TUDCA-ALS Study","status":"UNKNOWN","sponsor":"Humanitas Mirasole SpA","startDate":"2021-10-25","conditions":"Amyotrophic Lateral Sclerosis","enrollment":184},{"nctId":"NCT03331432","phase":"NA","title":"Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2015-10-28","conditions":"Type 2 Diabetes Mellitus","enrollment":8},{"nctId":"NCT01857284","phase":"PHASE3","title":"Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis","status":"COMPLETED","sponsor":"Beijing Friendship Hospital","startDate":"2009-09","conditions":"Primary Biliary Cirrhosis","enrollment":216}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Taurolite"],"phase":"phase_3","status":"active","brandName":"Tauroursodeoxycholic Acid Capsules","genericName":"Tauroursodeoxycholic Acid Capsules","companyName":"Beijing Friendship Hospital","companyId":"beijing-friendship-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tauroursodeoxycholic acid capsules are a small molecule intervention with an unknown mechanism of action. They have been studied in clinical trials for various conditions, including influenza vaccine response, diabetic macular edema, type 2 diabetes mellitus, vasodilation, and arterial stiffness.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}